DRIO Average Annual Return Since 2013
Growth of $10,000.00
Without Dividends Reinvested Into DRIO

Also see:
DRIO stock yearly return 2014
DRIO stock yearly return 2015
DRIO stock yearly return 2016
DRIO stock yearly return 2017
DRIO stock yearly return 2018
DRIO stock yearly return 2019
DRIO stock yearly return 2020
DRIO stock yearly return 2021
DRIO stock yearly return 2022
DRIO YTD return
Compare DRIO average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 04/10/2013
End date: 03/23/2023
Start price/share: $2.65
End price/share: $4.10
Dividends collected/share: $0.00
Total return: 54.72%
DRIO Average Annual Return: 4.48%
Starting investment: $10,000.00
Ending investment: $15,470.25
Years: 9.96

DRIO average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
DarioHealth is a Global Digital Therapeutics company. Co.'s suit of digital offerings include: Dario Metabolic, which is designed to address co-occurring metabolic health needs - diabetes, hypertension, and weight management; Dario Musculoskeletal, which is a digital physical therapy programs and posture training helps people improve strength and mobility by using a combination of software, wearable biofeedback sensors, and coaching; Dario Behavioral Health, which optimizes access to evidence-based care by using an AI-driven screener to triage users and connect them to support across a range of mental health needs; and Dario Full Suite, which provides the maximum benefit for its partners. The DRIO average annual return since 2013 is shown above.

The Average Annual Return on the DRIO average annual return since 2013 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether DRIO average annual return since 2013 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the DRIO average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree DRIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
DarioHealth (DRIO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

DRMA Average Annual Return
DRRX Average Annual Return
DSGN Average Annual Return
DTIL Average Annual Return
DVA Average Annual Return
DVAX Average Annual Return
DXCM Average Annual Return
DYAI Average Annual Return
DYN Average Annual Return
DYNT Average Annual Return
More Healthcare companies »


DRIO Average Annual Return Since 2013 | www.AverageAnnualReturn.com | Copyright © 2021 - 2023, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.